Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
10/2005
10/05/2005CN1678326A 2'-C-methyl-3'-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections
10/05/2005CN1678320A N-biarylmethyl aminocycloalkanecarboxamide derivatives
10/05/2005CN1678317A 1-amido-4-phenyl-4-benzyloxymethyl-piperidine derivatives and related compounds as neurokinin-1(NK-1) antagonists for the treatment of emesis, depression, anxiety and cough
10/05/2005CN1678315A Prodrugs of imidazole derivatives, for use as proton pump inhibitors in the treatment of e.g. peptic ulcers
10/05/2005CN1678309A Tropical formulation comprising at least 5% of metronidazole in white petrolatum and its use in the anal and rectal region
10/05/2005CN1676520A Kuh-seng flavone extract and preparation and use thereof
10/05/2005CN1676162A Thymic penta peptide injection liquid
10/05/2005CN1676161A Chinese medicine formulation for treating upper respiratory system disease, skin infection and haemorr hoids and its preparing method
10/05/2005CN1676157A Chinese medicine for treating colonitis
10/05/2005CN1676148A Chinese herbal medicine formula for treating hepatitis
10/05/2005CN1676147A Chinese herbal medicine formula for treating gastric and duodenal ulcer
10/05/2005CN1676146A Medicine for treating gastric ulcer
10/05/2005CN1676145A Tooth-care gum of radix astragali
10/05/2005CN1676144A Tooth-care mouth-cleaning gum of radio astragali
10/05/2005CN1676140A Composition for treating hepatitis B and process for making same
10/05/2005CN1676137A Sichuan China berry anti-inflammation oral liquor
10/05/2005CN1676136A Compound vitamin U atropa belladonna bismuth-aluminium medicine table for treating gastric ulcer
10/05/2005CN1676128A Carsickness medicine
10/05/2005CN1221554C Pyrano [2, 3-C] imidazo[-1, 2-A] pyridine derivatives and mecicine composition for treatment of traitement gastrointestinal disorders
10/05/2005CN1221553C Tricyclic imidazopyridines and medicine composition thereof
10/05/2005CN1221538C Calcium salts of 1, 5-benzodiazepine derivatives, process for producing salts and drugs containing same
10/05/2005CN1221535C Spiroimidazolidine derivatives, their prepn. their use and pharmaceutical preparation comprising them
10/05/2005CN1221534C Substited 8-arylquinoline phosphodiesterase-4 inhibitors
10/05/2005CN1221286C Irradiation of ispaghula and product thereof
10/05/2005CN1221281C Oral, nasal and pulmonary dosage formulations of copolymer1
10/05/2005CN1221272C Medicine for curing gastropathy and treating trauma and preparation method thereof
10/05/2005CN1221262C Phthalazine derivatives for treating inflammatory diseases
10/05/2005CN1221182C Synanthrin products with improved nutritional properties
10/04/2005US6951940 Analgesics, antiinflammatory agents, antiallergens, autoimmune disease, cardiovascular disorders
10/04/2005US6951938 Aryl fused azapolycyclic compounds
10/04/2005US6951918 Treatment of diseases characterized by excessive deposits of fibrillar interstitial collagens that are resistant to proteolyic degradation thus leading to symptoms of fibrosis
10/04/2005US6951889 7-acetamidinyl derivatives
10/04/2005US6951876 Sulfamoylheteroaryl pyrazole compounds as anti-inflammatory/analgesic agents
10/04/2005US6951874 Compounds
10/04/2005US6951871 Indole derivatives useful as histamine H3 antagonists
10/04/2005US6951865 Fused heterotricyclic compounds, process for preparing the compounds and drugs containing the same
10/04/2005US6951861 Chemical compounds
10/04/2005US6951858 Substituted 1,2,4-triazine-3,5-diones; male and female sex hormone related conditions
10/04/2005US6951843 Peptide derivatives and their pharmaceutically acceptable salts, thereof, processes for preparation of both and use thereof
10/04/2005US6951650 Antigenic class of avian reoviruses
09/2005
09/29/2005WO2005090405A1 Subtype of humanized antibody against interleukin-6 receptor
09/29/2005WO2005090340A1 Piperidine-1-carboxamide derivative
09/29/2005WO2005089784A1 Composition for oral cavity
09/29/2005WO2005089775A1 Treatment and prevention of enterotoxigenic escherichia coli diarrhoeas
09/29/2005WO2005089740A1 Coenzyme q composition with long-term persistence in blood
09/29/2005WO2005089714A1 Emulsion stabilizer
09/29/2005WO2005063801A3 Method for decreasing the contact between hepta-repeat region s of the corona-virus spike proteins and use thereof
09/29/2005US20050215786 Process for 5-[[2(r)-[1(r)-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3(s)-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-3h-1,,2,4-triazol-3-one
09/29/2005US20050215640 HMB compositions and uses thereof
09/29/2005US20050215613 with indazole or thienopyrazole compounds such as 3-(5'-hydroxymethyl-2'-furyl)-1-benzyl-indazole
09/29/2005US20050215609 Novel uses of prostaglandin d2, prostaglandin d2 agonist and prostaglandin d2 antagonist
09/29/2005US20050215594 Diabetes, obesity, urogenital disorders, cardiovascular disorders, atherosclerosis; 4-[(2R)-2-(([(2R)-2-(3-chlorophenyl)-2-hydroxyethyl]amino)methyl)-3,4-dihydro-2H-chromen-6-yl]benzoic acid for example
09/29/2005US20050215593 Kaposi's sarcoma; Crohn's disease
09/29/2005US20050215592 Methods for assessing, improving, or maintaining urogenital health in postmenopausal woman
09/29/2005US20050215559 2-substituted, especially 2-amino-substituted, e.g., [N-(1-ethyl)propyl]-5-(2,4-dimethoxyphenyl)-3,6-dimethylpyrazine-2-amine; bind with high affinity and high selectivity to CRF1 receptors and are used to treat central nervous system disorders
09/29/2005US20050215557 For therapy and prophylaxis of inflammatory diseases, asthma, atopic dermatitis, urticaria, allergic diseases, nephritis, nephropathy, hepatitis, arthritis or rheumatoid arthritis etc
09/29/2005US20050215553 For therapy and prophylaxis of cardiovascular, central nervous system, inflammatory, and bone diseases as well as infectious diseases and certain cancers
09/29/2005US20050215550 Pyrazole-derived kinase inhibitors and uses thereof
09/29/2005US20050215549 TACE inhibitors
09/29/2005US20050215547 Optically active pyridine derivative and a medicament containing the same
09/29/2005US20050215532 Tetracycline compounds for treatment of cryptosporidium parvum related disorders
09/29/2005US20050215500 aoaligonucleotides containing activated lymphocytes; antibody therapy; skin disorders; antiallergens
09/29/2005US20050215496 Preparation and diabetic use of Gibberellins
09/29/2005US20050215480 Alpha conotoxin peptides with analgesic properties
09/29/2005US20050214334 Composition for topical substance delivery
09/29/2005US20050214320 Mycobacterium vaccae; enhancement of immune Th1 or Th2 responses to heterologous antigens; tuberculosis, autoimmune thyroiditis, insulin-dependent diabetes mellitus, multiple sclerosis, Crohn's disease, peptic ulcers, organ transplant rejection, sarcoidosis, asthma, allergic rhinitis, cancer, lupus
09/29/2005US20050214291 Treatment method
09/29/2005US20050214281 G-protein coupled receptor
09/29/2005US20050214272 Antiinflammatory agents for gastrointestinal inflammation involved with inflammatory bowel disease or irritable bowel syndrome
09/29/2005US20050214247 Glycodendrimers having biological activity
09/29/2005CA2562388A1 Emulsion-stabilized preparation
09/29/2005CA2560174A1 Y4 selective receptor agonists for therapeutic interventions
09/29/2005CA2559416A1 Composition for oral cavity
09/29/2005CA2559127A1 Methods and compositions for the treatment of conditions related to gastric acid secretion
09/29/2005CA2558126A1 The treatment of inflammatory disorders and pain using beta-aminoalcohols
09/29/2005CA2555363A1 Coenzyme q compositions persisting in blood
09/28/2005EP1580192A2 16-Hydroxyestratrienes as selective estrogens
09/28/2005EP1579868A2 Use of IL-11 for treating various diseases
09/28/2005EP1578988A2 Protein based tnf-alpha variants for the treatment of tnf-alpha related disorders
09/28/2005EP1578914A2 Human ion channels
09/28/2005EP1578771A2 Remodeling and glycoconjugation of peptides
09/28/2005EP1578385A2 Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders
09/28/2005EP1578342A2 Process for preparation of programmed liberation composition with venlafaxine and the resulting product
09/28/2005EP1448521B1 Derivatives of andrimide and moiramide b having antibacterial properties
09/28/2005EP1373258B1 Ether derivatives useful as inhibitors of pde4 isozymes
09/28/2005EP1361880B1 6-substituted pyrido-pyrimidines
09/28/2005EP1345937B1 Quinuclidine carbamate derivatives and their use as m3 antagonists
09/28/2005EP1307430B1 Nonpeptide substituted spirobenzoazepines as vasopressin antagonists
09/28/2005EP1299365B1 2-aminothiazoline derivatives and their use as no-synthase inhibitors
09/28/2005EP1299103B1 4,5-dihydro-thiazo-2-ylamine derivatives and their use as no-synthase inhibitors
09/28/2005EP1289559B8 Combinations of enzyme inhibitor-containing preparations and the use thereof
09/28/2005EP1265838B1 Novel fatty acid analogous
09/28/2005EP1228072B1 Pdgf receptor kinase inhibitory compounds, their preparation, purification and pharmaceutical compositions including same
09/28/2005EP1178781B1 Multilayer pharmaceutical product for release in the colon
09/28/2005EP1163227B1 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, and processes for preparing them
09/28/2005EP1008344B1 New dicaffeoylquinic acid derivatives and their use for treating hepatitis b
09/28/2005EP0963200B1 Compositions for inhibition of angiogenesis comprising thalodomide and a nsaid
09/28/2005CN1675229A Sulfur-containing phospholipid derivatives
09/28/2005CN1675224A Fused heterocyclic isoxazoline derivatives and their use as anti-depressants
09/28/2005CN1675215A Aryl-substituted diazabicycloalkanes as nicotinic acetylcholine agonists
1 ... 682 683 684 685 686 687 688 689 690 691 692 693 694 695 696 697 698 699 700 701 702 ... 1258